AzTrials
AzTrials

Patient/Ventilator AsynchronyNAVAChildrenNCT01159106

The Use of Neurally Adjusted Ventilatory Assist (NAVA) Versus Pressure Support During Asynchrony in Children

A study testing Pressure Support Ventilation and Neurally adjusted ventilatory assist (NAVA) in people with Patient/Ventilator Asynchrony, run by Hospital Universitario La Paz at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the current study is to compare the application neurally adjusted ventilatory assist (NAVA) to optimize pressure support ventilation in 12 pediatric patients. Read more about this study

Who is it for?
Ages 1 month to 18 years
Conditions the study is for
Patient/Ventilator Asynchrony
What is being tested?
Pressure Support Ventilation and Neurally adjusted ventilatory assist (NAVA)
How many people
12 participants
Where
1 siteSpain
Study dates
Jul 2010to Jul 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Trigger asynchrony
  • Breath initiation asynchrony
  • Breath termination asynchrony
  • Patient ventilated by Servo i (Maquet Critical Care AB,Solna,Sweden)
  • Patients breathing spontaneously with no control breaths

Who cannot join

  • Shock
  • Agitation
  • Asynchrony caused by pain
  • Abundant tracheal secretions

Trial locations and contacts

1 site in 1 country.

Pedro De La Oliva, MD, PhD contact

poliva.hulp@salud.madrid.org

Spain1 site, 1 recruiting
  • Hospital Universitario La Paz

    Madrid, 28046

    Pedro de la Oliva, MD PhD, +347277149, poliva.hulp@salud.madrid.org

    Pedro de la Oliva, MD PhD

    Recruiting

Other trials in Spain

About this study

Official title: The Use of NAVA vs. Pressure Support During Asynchrony in Children

The aim of the current study is to compare the application neurally adjusted ventilatory assist (NAVA) to optimize pressure support ventilation in 12 pediatric patients.

Read the detailed description

Asynchrony during assisted ventilation in children is common because of the presence of uncuffed artificial airways and their rapid ventilatory rate with small volumes compared to adults.As a result, the most common approach to ventilatory support in children is pressure ventilation, since pressure targeted ventilation allows gas delivery to vary based on patient demand. In addition, many manufacturers have incorporated adjuncts designed to improve synchrony in pressure targeted ventilation. Most of today's ICU ventilators incorporate rise time and control of the breath termination criteria in pressure ventilation by either altering inspiratory time directly or adjusting the inspiratory flow termination criteria in pressure support ventilation. In addition, careful adjustment of trigger sensitivity, and insuring driving pressure is appropriately set to avoid large tidal volumes improves synchrony in many patients. However, in spite of all of these potential adjustments many pediatric patients are still asynchronous.

A recently released new mode of ventilation, NAVA (neurally adjusted ventilatory assist) is designed to reduce the asynchrony that exists between the ventilator and the patient. With NAVA, gas delivery from the mechanical ventilator is triggered, controlled and cycled by the diaphragmatic EMG signal (Edi). The ventilator is aware of the change in diaphragmatic EMG by the insertion of a specially designed nasogastric tube (NGT) with EMG electrodes that cross the diaphragm. This NGT also functions similar to any standard NGT. NAVA is used to control all aspects of assisted ventilatory support. A number of preliminary studies in neonates and pediatric patients have demonstrated that patient ventilator synchrony is improved with the application of NAVA. In general, tidal volumes delivered by the ventilator are decreased, respiratory rates increased and peak inspiratory pressures decreased. In these studies, triggering and cycling of the ventilator are controlled by the diaphragmatic EMG in more than 70 % of the time. If the EMG signal does not activate or terminate positive pressure backup flow/pressure/time signal, control gas delivery -as is customary in standard modes of ventilatory support- takes over.

We hypothesize that the use of NAVA will improve trigger and flow synchrony in children and insure that tidal volumes are normalized (6 to 8 ml/kg) in these patients.

Asynchrony will be studied in 12 mechanically ventilated pediatric patients in the Pediatric ICU at Hospital Universitario Materno-Infantil La Paz in Madrid, Spain.

The study protocol has 5 phases

  • Phase 0: patient asynchrony documentation and 10 min recording
  • Phase 1: NAVA catheter insertion and 10 min recording in basal ventilatory mode after 20 min stabilization
  • Phase 2: Pressure support is optimized and 10 min recording after 20 min stabilization
  • Phase 3: NAVA mode ventilation and 10 min recording after 20 min stabilization
  • Phase 4: Pressure support ventilation and 10 min recording after 20 min stabilization
Being tested
Pressure Support Ventilation, Neurally adjusted ventilatory assist (NAVA)
Keywords
Positive Pressure Ventilation, Neurally Adjusted Ventilatory Assist, Patient/ventilator Asynchrony, Pediatric patient, Infant
Medical subject headings
Patient-Ventilator Asynchrony

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pressure Support VentilationOther

    Spontaneous mode of ventilation whereby the patient initiates the breath and the ventilator delivers support with the preset pressure value

  • Neurally adjusted ventilatory assist (NAVA)Other

    Gas delivery from the mechanical ventilator is triggered, controlled and cycled by the diaphragmatic EMG signal (Edi).

    The ventilator is aware of the change in diaphragmatic EMG by the insertion of a specially designed nasogastric tube with EMG electrodes that cross the diaphragm.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of asynchrony

    Number of each defined forms of asynchrony per minute during pressure support and during NAVA Six forms of asynchrony will be identified during optimal pressure support and optimal NAVA: trigger asynchrony, breath initiation asynchrony and breath termination asynchrony, demand asynchrony, inspiratory asynchrony and neuro-asynchrony

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2010 (estimated)
  2. Study startJul 2010
  3. Primary completionJul 2011 (estimated)
  4. Study completionJul 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Intervention model
Crossover
Masking
None (open label)
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01159106
Sponsor's protocol ID
HULP-PI-3132
Acronym
NAVAChildren
Status last verified
Jul 2010
First submitted
8 Jul 2010
Last updated
9 Jul 2010
Results posted
No
Data monitoring committee
No

Publications

  • Beck J, Tucci M, Emeriaud G, Lacroix J, Sinderby C. Prolonged neural expiratory time induced by mechanical ventilation in infants. Pediatr Res. 2004 May;55(5):747-54. doi: 10.1203/01.PDR.0000119368.21770.33. Epub 2004 Jan 22.

    PubMed 14739354
  • Spahija J, de Marchie M, Albert M, Bellemare P, Delisle S, Beck J, Sinderby C. Patient-ventilator interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med. 2010 Feb;38(2):518-26. doi: 10.1097/CCM.0b013e3181cb0d7b.

    PubMed 20083921
  • Breatnach C, Conlon NP, Stack M, Healy M, O'Hare BP. A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population. Pediatr Crit Care Med. 2010 Jan;11(1):7-11. doi: 10.1097/PCC.0b013e3181b0630f.

    PubMed 19593246
  • de la Oliva P, Schuffelmann C, Gomez-Zamora A, Villar J, Kacmarek RM. Asynchrony, neural drive, ventilatory variability and COMFORT: NAVA versus pressure support in pediatric patients. A non-randomized cross-over trial. Intensive Care Med. 2012 May;38(5):838-46. doi: 10.1007/s00134-012-2535-y. Epub 2012 Apr 6.

    PubMed 22481227

Questions about this trial

What is this clinical trial studying?

A study testing Pressure Support Ventilation and Neurally adjusted ventilatory assist (NAVA) in people with Patient/Ventilator Asynchrony, run by Hospital Universitario La Paz at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pedro De La Oliva, MD, PhD (poliva.hulp@salud.madrid.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of asynchrony (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01159106, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in